SLHG - SLHG STOCK NEWS

Skylight Health Group (NASDAQ: SLHG) will participate in the Lake Street Capital Markets' 5th Annual Best Ideas Growth (BIG5) Conference on September 14, 2021. This invitation-only event connects over 100 small-cap companies with top institutional investors, facilitating direct interactions through virtual meetings. Skylight Health aims to enhance patient outcomes by transitioning from fee-for-service to value-based care. The company operates a multi-state primary care network in the U.S., focusing on quality care delivery.

Skylight Health Group Inc. (NASDAQ:SLHG) has appointed Mohammad Bataineh as the new President, transitioning from a previous role. Bataineh brings over 25 years of experience in primary care and healthcare M&A, and will oversee all internal functions. Co-founder Kash Qureshi shifts focus to Corporate Affairs while maintaining executive leadership. The move is intended to streamline operations and support the company's expansion strategy in the U.S. healthcare market. The company also granted 156,000 options to Bataineh and 216,000 options to other employees as part of its quarterly grants.

Skylight Health Group (SLHG) reported a 184% year-over-year revenue growth to $10.5 million for Q2 2021, up 103% from Q1 2021. This growth was driven by strategic acquisitions and a 13% organic growth in existing clinics. Despite revenue growth, the company faced an Adjusted EBITDA loss of $1.5 million due to investments in operational improvements. The company is positioned for future growth through its participation in the Medicare Shared Savings Program starting January 2022, bolstering its focus on value-based care.

Skylight Health Group (NASDAQ:SLHG) announced its 2021 Q2 financial results set for release after market close on August 16, 2021. The company will hold a conference call to discuss these results on August 17, 2021, at 8:30 AM EDT. Skylight Health focuses on transitioning healthcare practices from fee-for-service to value-based care models. This approach aims to enhance patient outcomes while reducing unnecessary healthcare costs, thereby improving financial performance for providers. Further information can be found on the company's website.

Skylight Health (NASDAQ:SLHG) has expanded its partnership with ClinEdge into Colorado, acting as a clinical research site. This partnership follows a successful trial in Massachusetts and marks the award of Skylight's first Colorado-based research project. The trial focuses on patient-centric research, enhancing Skylight's value proposition. Recruitment for the study has begun, expected to conclude by Q3 2021. Additionally, Skylight's shareholders approved an omnibus long-term incentive plan to attract key individuals, allowing for options equivalent to 10% of outstanding shares.

Skylight Health Group (NASDAQ: SLHG) announced the acquisition of ACO Partners LLC, which will join the Medicare Shared Savings Program effective January 1, 2022. This acquisition allows Skylight to engage in value-based care directly with CMS, potentially realizing shared savings of 40% to 75% on Medicare beneficiaries. The ACO will enhance Skylight’s contracting capabilities and provide access to crucial cost and quality data, aiming to improve patient outcomes. Skylight expects significant benefits from this acquisition, including direct CMS contracting, national payor opportunities, and additional provider participation.

Skylight Health Group (NASDAQ: SLHG) has appointed Dr. Kit Brekhus as Chief Medical Officer, succeeding Dr. Georges Feghali, who remains an advisor. Dr. Brekhus has over 25 years of experience in primary care and has previously managed large healthcare networks. His leadership aims to strengthen Skylight's focus on patient-centered, value-based healthcare models. Dr. Feghali expressed confidence in Dr. Brekhus's ability to build upon the clinical foundation he established. Skylight Health operates a multi-state primary care network focused on improving patient outcomes.

Skylight Health Group Inc (NASDAQ:SLHG) announced the results of its annual general meeting held on June 29, 2021. Shareholders approved all agenda items, including the election of directors: Pradyum Sekar, Kashaf Qureshi, Norton Singhavon, Grace Mellis, Tom Brogan, Peter Cummins, and Patrick McNamee.

Moreover, PwC was appointed as the company's auditors for the upcoming year, and the 2021 Omnibus Plan received shareholder approval. Detailed voting results can be found on SEDAR.

Skylight Health Group (NASDAQ: SLHG; TSXV: SLHG) announced the acquisition of Doctors Center Inc., a primary care group in Jacksonville, Florida, adding four clinical locations to its network. This acquisition expands Skylight's patient count by 6,000 lives, enhancing its value-based care offerings. In 2020, Doctors Center reported unaudited revenues of approximately CAD $3.2 million with a 10% expected EBITDA margin. The move aims to strengthen Skylight's presence in Northeast Florida and is part of its strategy to enhance managed care programs.